Among 12 analysts covering Himax Tech (NASDAQ:HIMX), 7 have Buy rating, 2 Sell and 3 Hold. Therefore 58% are positive. Himax Tech has $18.0 highest and $4.0 lowest target. $10.16’s average target is 23.90% above currents $8.2 stock price. Himax Tech had 49 analyst reports since August 10, 2015 according to SRatingsIntel. Morgan Stanley downgraded the shares of HIMX in report on Monday, November 27 to “Equal-Weight” rating. Lake Street maintained Himax Technologies, Inc. (NASDAQ:HIMX) rating on Friday, February 5. Lake Street has “Buy” rating and $9 target. On Tuesday, December 5 the stock rating was maintained by Northland Capital with “Buy”. The company was downgraded on Wednesday, January 11 by Roth Capital. Lake Street maintained the shares of HIMX in report on Friday, October 16 with “Buy” rating. Robert W. Baird maintained Himax Technologies, Inc. (NASDAQ:HIMX) on Wednesday, August 30 with “Buy” rating. The stock of Himax Technologies, Inc. (NASDAQ:HIMX) earned “Neutral” rating by Credit Suisse on Wednesday, January 18. The stock has “Buy” rating by Robert W. Baird on Friday, August 4. Morgan Stanley initiated it with “Overweight” rating and $8.50 target in Monday, November 23 report. Morgan Stanley downgraded Himax Technologies, Inc. (NASDAQ:HIMX) on Tuesday, February 7 to “Underweight” rating.
Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer had 74 analyst reports since July 29, 2015 according to SRatingsIntel. As per Tuesday, September 13, the company rating was maintained by Jefferies. The firm has “Buy” rating by Jefferies given on Thursday, April 7. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Piper Jaffray on Friday, August 14. The stock has “Hold” rating by Argus Research on Wednesday, November 2. On Thursday, July 20 the stock rating was downgraded by Credit Suisse to “Neutral”. The company was maintained on Monday, April 18 by Goldman Sachs. BMO Capital Markets maintained the stock with “Buy” rating in Friday, December 15 report. Morgan Stanley maintained Pfizer Inc. (NYSE:PFE) rating on Friday, April 7. Morgan Stanley has “Neutral” rating and $38 target. The company was reinitiated on Thursday, April 7 by JP Morgan. As per Monday, June 12, the company rating was maintained by BMO Capital Markets. See Pfizer Inc. (NYSE:PFE) latest ratings:
30/01/2018 Broker: Barclays Capital Rating: Buy New Target: $41.0
31/01/2018 Broker: Credit Suisse Old Rating: Neutral New Rating: Neutral Old Target: $37 New Target: $39 Maintain
31/01/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $41 New Target: $43 Maintain
31/01/2018 Broker: Leerink Swann Old Rating: Market Perform New Rating: Market Perform Old Target: $35 New Target: $38 Maintain
30/01/2018 Broker: Bank of America Rating: Buy New Target: $40.0
28/01/2018 Broker: SunTrust Rating: Hold New Target: $40.0 Maintain
16/01/2018 Broker: Jefferies Rating: Hold New Target: $40.0 Maintain
15/12/2017 Broker: BMO Capital Markets Rating: Buy New Target: $39.0 Maintain
21/11/2017 Broker: BMO Capital Markets Rating: Buy New Target: $39.0 Maintain
01/11/2017 Broker: UBS Rating: Buy New Target: $38.0 Maintain
Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies to consumer electronics worldwide. The company has market cap of $1.41 billion. The firm operates through Driver IC and Non-Driver Products divisions. It has a 160.78 P/E ratio. It offers display driver integrated circuits and timing controllers used in televisions (TVs), laptops, monitors, mobile phones, tablets, digital cameras, car navigation, and other consumer electronics devices.
The stock decreased 1.09% or $0.09 during the last trading session, reaching $8.2. About 6.65M shares traded or 14.47% up from the average. Himax Technologies, Inc. (NASDAQ:HIMX) has declined 20.28% since February 14, 2017 and is downtrending. It has underperformed by 36.98% the S&P500.
Analysts await Himax Technologies, Inc. (NASDAQ:HIMX) to report earnings on February, 15. They expect $0.14 earnings per share, up 366.67% or $0.11 from last year’s $0.03 per share. HIMX’s profit will be $24.09 million for 14.64 P/E if the $0.14 EPS becomes a reality. After $0.02 actual earnings per share reported by Himax Technologies, Inc. for the previous quarter, Wall Street now forecasts 600.00% EPS growth.
Since August 21, 2017, it had 0 buys, and 8 selling transactions for $12.56 million activity. Shares for $6.70 million were sold by READ IAN C on Thursday, August 31. 8,000 shares were sold by JOHNSON RADY A, worth $296,560. MACKENZIE ALEXANDER R sold $249,750 worth of stock or 6,750 shares. 94,409 shares valued at $3.21 million were sold by DAMELIO FRANK A on Thursday, August 31. Shares for $1.34 million were sold by SUSMAN SALLY. OLSON LAURIE J sold $263,693 worth of stock or 8,064 shares.
The stock increased 0.81% or $0.28 during the last trading session, reaching $34.94. About 20.45M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since February 14, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.
Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.02, from 0.94 in 2017Q2. It improved, as 53 investors sold Pfizer Inc. shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Proshare Advisors Lc accumulated 846,307 shares. Hoertkorn Richard Charles holds 0.77% in Pfizer Inc. (NYSE:PFE) or 33,975 shares. Nelson Van Denburg & Campbell Wealth Ltd Liability Company owns 45,313 shares or 0.64% of their US portfolio. Martin Currie holds 325,376 shares. Pathstone Family Office Limited Com reported 791 shares stake. Tdam Usa holds 0.58% of its portfolio in Pfizer Inc. (NYSE:PFE) for 278,582 shares. Amg National Tru Bancorp holds 0.01% in Pfizer Inc. (NYSE:PFE) or 5,753 shares. Eastern National Bank holds 0.37% of its portfolio in Pfizer Inc. (NYSE:PFE) for 146,263 shares. Bridges Invest owns 52,942 shares for 0.24% of their portfolio. Retirement Sys Of Alabama has invested 0.76% in Pfizer Inc. (NYSE:PFE). 118 were reported by Rocky Mountain Advisers Limited Com. Sigma Planning invested in 128,292 shares. Partnervest Advisory Services Ltd Liability Co owns 20,514 shares or 0.36% of their US portfolio. Channing Ltd Com invested in 0.29% or 218,173 shares. St Germain D J Inc holds 0.54% or 121,813 shares.